Edition:
United States

CanniMed Therapeutics Inc (CMED.TO)

CMED.TO on Toronto Stock Exchange

32.80CAD
20 Apr 2018
Change (% chg)

$0.18 (+0.55%)
Prev Close
$32.62
Open
$32.60
Day's High
$33.05
Day's Low
$32.30
Volume
16,602
Avg. Vol
382,050
52-wk High
$46.00
52-wk Low
$7.32

Chart for

About

CanniMed Therapeutics Inc is a Canada-based plant biopharmaceutical company. It is specialized in the production of pharmaceutical-grade cannabis and offers a range of pharmaceutical-grade cannabis products. In addition, the Company has a plant biotechnology research and product development program focused on the production of... (more)

Overall

Beta: --
Market Cap(Mil.): $812.02
Shares Outstanding(Mil.): 24.76
Dividend: --
Yield (%): --

Financials

  CMED.TO Industry Sector
P/E (TTM): 323.79 31.01 33.60
EPS (TTM): 0.10 -- --
ROI: 2.48 13.60 13.19
ROE: 2.84 15.26 15.00

Pot producer Aurora gets final regulatory nod for CanniMed purchase

Canada's No.2 marijuana producer Aurora Cannabis Inc on Wednesday received final regulatory approval for the purchase of smaller rival CanniMed Therapeutics Inc , which would make it the world's most valuable weed producer.

Feb 28 2018

Pot producer Aurora gets final regulatory nod for CanniMed purchase

Feb 28 Canada's No.2 marijuana producer Aurora Cannabis Inc on Wednesday received final regulatory approval for the purchase of smaller rival CanniMed Therapeutics Inc, which would make it the world's most valuable weed producer.

Feb 28 2018

BRIEF-Aurora Cannabis Announces Receipt Of Final Regulatory Approval For CanniMed Therapeutics Acquisition

* AURORA CANNABIS ANNOUNCES RECEIPT OF FINAL REGULATORY APPROVAL FOR CANNIMED THERAPEUTICS ACQUISITION AND ITS INTENTION TO TAKE-UP AS SOON AS MINIMUM TENDER CONDITION IS MET

Feb 28 2018

BRIEF-Aurora Cannabis And Cannimed Therapeutics File Offer Documents For Previously Announced Friendly Acquisition

* AURORA CANNABIS AND CANNIMED THERAPEUTICS FILE OFFER DOCUMENTS FOR PREVIOUSLY ANNOUNCED FRIENDLY ACQUISITION Source text for Eikon: Further company coverage:

Feb 06 2018

CANADA STOCKS-Toronto shares hit six-week low as resources drag

Jan 29 Canada's main stock index fell on Monday, touching a six-week low as energy and other resource shares tumbled alongside commodity prices.

Jan 29 2018

UPDATE 4-Canada's Aurora Cannabis to buy rival to create world's most valuable weed firm

Jan 24 Canada's No. 2 marijuana producer Aurora Cannabis Inc has agreed to buy smaller rival CanniMed Therapeutics Inc for C$1.1 billion ($852 million) as companies jostle to benefit from the country's legalization of recreational marijuana use later this year.

Jan 24 2018

BRIEF-Aurora Cannabis, Cannimed Therapeutics Agree To Terms On Friendly Transaction

* AURORA CANNABIS AND CANNIMED THERAPEUTICS AGREE TO TERMS ON FRIENDLY TRANSACTION

Jan 24 2018

Cannabis producer Aurora to buy CanniMed for C$1.1 bln

Jan 24 Canadian marijuana producer Aurora Cannabis on Wednesday agreed to buy CanniMed Therapeutics Inc for about C$1.1 billion ($892.21 million), gearing up to meet an expected surge in demand at home and globally.

Jan 24 2018

BRIEF-CanniMed Therapeutics Announces Continued Discussions With Aurora

* CANNIMED THERAPEUTICS ANNOUNCES CONTINUED DISCUSSIONS WITH AURORA

Jan 23 2018

Canadian cannabis firm Aurora in talks to buy both CanniMed and Newstrike: sources

TORONTO Canadian marijuana producer Aurora Cannabis Inc is in talks with rivals CanniMed Therapeutics Inc and Newstrike Resources Ltd to buy both businesses in a friendly deal that would create the nation's top weed company, people familiar with the matter told Reuters on Friday.

Jan 19 2018

Earnings vs. Estimates